2014 Buprenorphine Summit Statement Of Proceedings

This document was released on September 22, 2014 by the U.S. Department of Health and Human Services for the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institute on Drug Abuse. The topics include issues related to access to buprenorphine; patient capacity and quality care; workforce considerations; the role of the provider training in improving access; buprenorphine for an opioid use disorder in special populations; and addressing health systems and reimbursement . . .